Biohaven (BHVN) News Today $29.82 -1.22 (-3.92%) As of 11:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Emerald Advisers LLC Buys Shares of 360,538 Biohaven Ltd. (NYSE:BHVN)Emerald Advisers LLC bought a new stake in Biohaven Ltd. (NYSE:BHVN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 360,538 shares of the company's stock, valued at approximately $13,466,000. Emerald Advisers LLC owned 0.36% of BiohaMarch 24 at 7:08 AM | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Shares Bought by Swiss National BankSwiss National Bank lifted its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 12.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 154,800 shares of the company's stock after buying an additional 16,800 sharesMarch 24 at 3:41 AM | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Position Boosted by Intech Investment Management LLCIntech Investment Management LLC lifted its stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 202.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 34,165 shares of the company's stock after purchasing an additional 22,858 shares duringMarch 23 at 4:27 AM | marketbeat.comMagnetar Financial LLC Purchases 32,702 Shares of Biohaven Ltd. (NYSE:BHVN)Magnetar Financial LLC increased its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 498.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,260 shares of the company's stock after buying an additional 32,702March 22 at 5:20 AM | marketbeat.com47% daling Biohaven bevestigt bearish Fair Value voorspelling InvestingProMarch 18, 2025 | nl.investing.comCharles Schwab Investment Management Inc. Increases Stock Holdings in Biohaven Ltd. (NYSE:BHVN)Charles Schwab Investment Management Inc. lifted its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 10.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 701,314 shares of the company's stock after purchasing anMarch 18, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVNMarch 17, 2025 | prnewswire.comBiohaven Ltd. (NYSE:BHVN) Shares Bought by Bank of New York Mellon CorpBank of New York Mellon Corp increased its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 9.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 295,078 shares of the company's stock after acquiring an additional 24,703March 14, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have received an average recommendation of "Buy" from the fifteen ratings firms that are currently covering the company, Marketbeat.com reports. Fourteen equities research analysts have rated the stock with a buy recommendation and one has giveMarch 12, 2025 | marketbeat.comPositive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority ReviewMarch 10, 2025 | tipranks.comBiohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025March 9, 2025 | insidermonkey.comMorgan Stanley Cuts Biohaven (NYSE:BHVN) Price Target to $63.00Morgan Stanley decreased their target price on shares of Biohaven from $69.00 to $63.00 and set an "overweight" rating on the stock in a research report on Friday.March 8, 2025 | marketbeat.comCantor Fitzgerald Decreases Earnings Estimates for BiohavenBiohaven Ltd. (NYSE:BHVN - Free Report) - Research analysts at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for shares of Biohaven in a report released on Tuesday, March 4th. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will earn ($6.80) per share foMarch 7, 2025 | marketbeat.comMorgan Stanley verlaagt koersdoel Biohaven-aandeel naar $ 63 van $ 69March 7, 2025 | nl.investing.comOptimistic Buy Rating for Biohaven Ltd. Amid Promising Drug Developments and Strategic Pipeline AdvancementsMarch 6, 2025 | tipranks.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Biohaven (NYSE:BHVN) Stock PriceJPMorgan Chase & Co. cut their price objective on shares of Biohaven from $72.00 to $68.00 and set an "overweight" rating for the company in a report on Wednesday.March 6, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Director Purchases $996,369.00 in StockBiohaven Ltd. (NYSE:BHVN - Get Free Report) Director John W. Childs bought 32,700 shares of Biohaven stock in a transaction that occurred on Tuesday, March 4th. The stock was bought at an average price of $30.47 per share, with a total value of $996,369.00. Following the completion of the acquisition, the director now owns 2,320,571 shares in the company, valued at approximately $70,707,798.37. The trade was a 1.43 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.March 6, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Director John W. Childs Buys 32,700 SharesMarch 6, 2025 | insidertrades.comH.C. Wainwright handhaaft koopadvies voor Biohaven-aandeel met koersdoel van $ 54March 5, 2025 | nl.investing.comBiohaven-directeur John Childs verwerft aandelen ter waarde van $ 996.238March 5, 2025 | nl.investing.comEstimating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)March 5, 2025 | finance.yahoo.comHC Wainwright Reaffirms "Buy" Rating for Biohaven (NYSE:BHVN)HC Wainwright reaffirmed a "buy" rating and issued a $54.00 price objective on shares of Biohaven in a research note on Tuesday.March 5, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVNMarch 4, 2025 | prnewswire.comBiohaven Ltd.’s Promising Therapeutic Developments and Strategic Focus Justify Buy RatingMarch 4, 2025 | tipranks.comBiohaven (NYSE:BHVN) Given Outperform Rating at Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and set a $61.00 price objective on shares of Biohaven in a research report on Tuesday.March 4, 2025 | marketbeat.comTD Cowen Keeps Their Buy Rating on Biohaven Ltd. (BHVN)March 4, 2025 | markets.businessinsider.comBiohaven Ltd. (BHVN) Gets a Buy from RBC CapitalMarch 4, 2025 | markets.businessinsider.comOptimistic Buy Rating for Biohaven Ltd. Amid Regulatory Prospects and Long-term Growth PotentialMarch 4, 2025 | tipranks.comY Intercept Hong Kong Ltd Has $315,000 Holdings in Biohaven Ltd. (NYSE:BHVN)Y Intercept Hong Kong Ltd lessened its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 68.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 8,445 shares of the company's stock after selling 18,344 shares during the period. Y Intercept Hong Kong LtMarch 4, 2025 | marketbeat.comPiper Sandler handhaaft koersdoel van $ 76 voor Biohaven-aandeelMarch 3, 2025 | nl.investing.comBiohaven Ltd.: Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300March 3, 2025 | finanznachrichten.deBiohaven’s BHV-1300 toont veelbelovende resultaten bij IgG-verlagingMarch 3, 2025 | nl.investing.comBiohaven reports ‘positive’ data from study of BHV-1300March 3, 2025 | markets.businessinsider.comBiohaven (NYSE:BHVN) Shares Down 6.1% Following Weak EarningsBiohaven (NYSE:BHVN) Stock Price Down 6.1% Following Weak EarningsMarch 3, 2025 | marketbeat.comBiohaven (NYSE:BHVN) Posts Quarterly Earnings Results, Misses Estimates By $0.29 EPSBiohaven (NYSE:BHVN - Get Free Report) announced its earnings results on Monday. The company reported ($1.85) earnings per share for the quarter, missing the consensus estimate of ($1.56) by ($0.29).March 3, 2025 | marketbeat.comBiohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300March 3, 2025 | prnewswire.comBiohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | prnewswire.comRhumbline Advisers Raises Stock Position in Biohaven Ltd. (NYSE:BHVN)Rhumbline Advisers boosted its position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 14.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 117,595 shares of the company's stockMarch 1, 2025 | marketbeat.comBiohaven (BHVN) Projected to Post Quarterly Earnings on ThursdayBiohaven (NYSE:BHVN) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comPeregrine Capital Management LLC Makes New $5.56 Million Investment in Biohaven Ltd. (NYSE:BHVN)Peregrine Capital Management LLC bought a new stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 148,879 shares of the company's stock, valued at approximately $5,561,000. Peregrine CapiFebruary 19, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Sees Large Decrease in Short InterestBiohaven Ltd. (NYSE:BHVN - Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 9,440,000 shares, a decline of 5.0% from the January 15th total of 9,940,000 shares. Based on an average trading volume of 972,100 shares, the days-to-cover ratio is currently 9.7 days.February 18, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of "Buy" from AnalystsBiohaven Ltd. (NYSE:BHVN - Get Free Report) has received an average rating of "Buy" from the fifteen brokerages that are covering the firm, Marketbeat reports. Fourteen analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The avFebruary 15, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Arvinas Holding Company (ARVN)February 13, 2025 | markets.businessinsider.comBiohaven Ltd. Receives FDA Priority Review for Troriluzole, Boosting Investor ConfidenceFebruary 13, 2025 | tipranks.comDeutsche Bank Initiates Coverage of Biohaven (BHVN) with Buy RecommendationFebruary 12, 2025 | msn.comWhy Biohaven Stock Triumphed on TuesdayFebruary 11, 2025 | fool.comBiohaven: NDA Review Of Troriluzole Isn't Only 2025 Catalyst On DeckFebruary 11, 2025 | seekingalpha.comBiohaven's troriluzole krijgt voorrangsbehandeling van FDA voor SCAFebruary 11, 2025 | nl.investing.comBiohaven aandeel stijgt na FDA-beoordeling en Deutsche Bank koopadviesFebruary 11, 2025 | nl.investing.comWhy Biohaven (BHVN) Stock Is Rallying TodayFebruary 11, 2025 | msn.com Remove Ads Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address BHVN Media Mentions By Week BHVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHVN News Sentiment▼0.590.63▲Average Medical News Sentiment BHVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHVN Articles This Week▼56▲BHVN Articles Average Week Remove Ads Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Viatris News Ascendis Pharma A/S News Vaxcyte News Qiagen News Roivant Sciences News Revolution Medicines News Sarepta Therapeutics News BridgeBio Pharma News Lantheus News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHVN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BHVN Stock Free BHVN Stock Alerts